Fanyun T. Kong

84 West Huaihai Road
Xuzhou, 221002, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

HBx-mediated GPT2 suppression promotes liver cancer development by downregulating ADH1A.

HBx-mediated GPT2 suppression promotes liver cancer development by downregulating ADH1A.

Journal: Cancer biology & medicine

Published: May 20, 2026

ALDH2 inhibits FASN stabilization via the E3 ligase CBL to suppress lipid accumulation and liver cancer development.

ALDH2 inhibits FASN stabilization via the E3 ligase CBL to suppress lipid accumulation and liver cancer development.

Journal: Biology direct

Published: November 29, 2025

The interplay between hepatitis B virus and antitumor drugs in the treatment of hepatocellular carcinoma.

The interplay between hepatitis B virus and antitumor drugs in the treatment of hepatocellular carcinoma.

Journal: Clinical and experimental medicine

Published: August 26, 2025

Regulation of pattern recognition receptor signaling by palmitoylation.

Regulation of pattern recognition receptor signaling by palmitoylation.

Journal: iScience

Published: January 29, 2025

HBV core protein enhances WDR46 stabilization to upregulate NUSAP1 and promote HCC progression.

HBV core protein enhances WDR46 stabilization to upregulate NUSAP1 and promote HCC progression.

Journal: Hepatology communications

Published: September 26, 2024

Hepatitis B virus core protein promotes liver cancer progression by stabilizing CANX and suppressing IRF7 transcription.

Hepatitis B virus core protein promotes liver cancer progression by stabilizing CANX and suppressing IRF7 transcription.

Journal: Acta pharmacologica Sinica

Published: September 04, 2024

Insight into the mechanisms regulating liver cancer stem cells by hepatitis B virus X protein.

Insight into the mechanisms regulating liver cancer stem cells by hepatitis B virus X protein.

Journal: Infectious agents and cancer

Published: June 28, 2024

Delta-Like Homolog 2 Facilitates Malignancy of Hepatocellular Carcinoma via Activating EGFR/PKM2 Signaling Pathway.

Delta-Like Homolog 2 Facilitates Malignancy of Hepatocellular Carcinoma via Activating EGFR/PKM2 Signaling Pathway.

Journal: Molecular carcinogenesis

Published: February 21, 2024

Hepatitis B virus core protein stabilizes RANGAP1 to upregulate KDM2A and facilitate hepatocarcinogenesis.

Hepatitis B virus core protein stabilizes RANGAP1 to upregulate KDM2A and facilitate hepatocarcinogenesis.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: September 30, 2023

Insights into the impact of hepatitis B virus on hepatic stellate cell activation.

Insights into the impact of hepatitis B virus on hepatic stellate cell activation.

Journal: Cell communication and signaling : CCS

Published: November 14, 2022

The emerging role of DEAD/H-box helicases in hepatitis B virus infection.

The emerging role of DEAD/H-box helicases in hepatitis B virus infection.

Journal: Frontiers in cellular and infection microbiology

Published: October 06, 2022

Antimicrobial and Anti-Inflammatory Activities of MAF-1-Derived Antimicrobial Peptide Mt6 and Its D-Enantiomer D-Mt6 against Acinetobacter baumannii by Targeting Cell Membranes and Lipopolysaccharide Interaction.

Antimicrobial and Anti-Inflammatory Activities of MAF-1-Derived Antimicrobial Peptide Mt6 and Its D-Enantiomer D-Mt6 against Acinetobacter baumannii by Targeting Cell Membranes and Lipopolysaccharide Interaction.

Journal: Microbiology spectrum

Published: October 03, 2022

Showing 1-12 of 47

Last Updated: 09/26/2026